Adrenal gland involvement in the regulation of renal 11 β-hydroxysteroid dehydrogenase 2

Renal 11 β-hydroxysteroid dehydrogenase 2 (HSD2) catalyzes the conversion of active glucocorticoids to inert 11 β-keto compounds, thereby preventing the illicit binding of these hormones to mineralocorticoid receptors (MRs) and, thus, conferring aldosterone specificity. Absence or inhibition of HSD2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Zallocchi, M.L
Otros Autores: Matkovic, L., Calvo, J.C, Damasco, M.C
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2004
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 17966caa a22015977a 4500
001 PAPER-4316
003 AR-BaUEN
005 20230518203351.0
008 190411s2004 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-16544364369 
024 7 |2 cas  |a 11beta hydroxysteroid dehydrogenase, 9041-46-7; chloride, 16887-00-6; corticosterone, 50-22-6; 11-beta-Hydroxysteroid Dehydrogenase Type 2, EC 1.1.1.146; Corticosterone, 50-22-6 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a JCEBD 
100 1 |a Zallocchi, M.L. 
245 1 0 |a Adrenal gland involvement in the regulation of renal 11 β-hydroxysteroid dehydrogenase 2 
260 |c 2004 
270 1 0 |m Zallocchi, M.L.; Facultad de Ciencias Exactas y Naturales, Ciudad Universitaria-Núnez, (1428) Buenos Aires, Argentina; email: mzallo@qb.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Agarwal, A., Expression of HSDIIK (NAD+dependent IIbeta-hydroxysteroid dehydrogenase) promoter constructs in renal cell lines (2000) Endocr Res, 26, pp. 289-302 
504 |a Akana, S., Dallman, M., Chronic cold in adrenalectomized, corticosterone (B)-treated rats: Facilitated corticotropin responses to acute restraint emerge as B increases (1997) Endocrinology, 138, pp. 3249-3258 
504 |a Alfaidy, N., Blot-Chabaud, M., Robic, D., Kenouch, S., Bourbouze, R., Bonvalet, J., Farman, N., Characteristics and regulation of 11 beta-hydroxysteroid dehydrogenase of proximal and distal nephron (1995) Biochem Bioph Acta, 1243, pp. 461-468 
504 |a Alfaidy, N., Blot-Chabaud, M., Bonvalet, J., Farman, N., Vasopressin potentiates mineralocorticoid selectivity by stimulating 11β-hydroxysteroid dehydrogenase in rat collecting duct (1997) J Clin Invest, 100, pp. 2437-2442 
504 |a Arriza, J., Weinberger, C., Cerelli, G., Glaser, T., Handelin, B., Housman, D., Evans, R., Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor (1987) Science, 237, pp. 268-275 
504 |a Audigé, A., Dick, B., Frey, B., Frey, M., Corman, B., Vogt, B., Glucocorticoids and 11β-hydroxysteroid dehydrogenase type 2 gene expression in the aging kidney (2002) Eur J Clin Invest, 32, pp. 411-420 
504 |a Bonvalet, J., Doignon, I., Blot-Chabaud, M., Pradelles, P., Farman, N., Distribution of 11β-hydroxysteroid dehydrogenase along the rabbit nephron (1990) J Clin Invest, 86, pp. 832-837 
504 |a Bradford, M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding (1976) Ann Biochem, 72, pp. 248-254 
504 |a Brooks, H.L., Ageloff, S., Kwon, T.H., Brandt, W., Terris, J.M., Seth, A., Michea, L., Knepper, M.A., DNA array identification of genes regulated in rat renal medulla in response to vasopressin infusion (2003) Am J Physiol Renal Physiol, 284, pp. F218-F228 
504 |a Carlton, B.D., Barlett, P., Basaran, A., Colling, K., Osis, I., Smith, M.K., Reproductive effects of alternative disinfectants (1986) Environ Health Perspect, 69, pp. 237-241 
504 |a Chen, K., Suh, J., Carr, A.C., Morrow, J.D., Zeind, J., Frei, B., Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload (2000) Am J Physiol Endocrinol Metab, 279, pp. E1406-E1412 
504 |a Dallman, M., Akana, S., Cascio, C., Darlington, D., Jacobson, L., Levin, N., Regulation of ACTH secretion: Variations on a theme of B (1987) Recent Prog Horm Res, 43, pp. 113-173 
504 |a Damasco, M.C., Coronel De Pedazzini, M., Corticosterone secretion by rats after adrenalectomy (1985) Acta Physiol Pharmacol Latin Am, 35, pp. 415-417 
504 |a Damasco, M.C., Díaz, F., Cenal, J., Lantos, C., Acute effects of three natural corticosteroids on the acid-base and electrolyte composition of urine in adrenalectomized rats (1979) Acta Physiol Latinoam, 29, pp. 305-314 
504 |a Damasco, M.C., Ansaldo, M., Malnic, G., Effects of adrenalectomy and acute replacement by corticosteroids on distal acidification (1990) Can J Physiol Pharmacol, 67, pp. 607-614 
504 |a Darnel, A., Archer, T., Yang, K., Regulation of 11β-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line (1999) J Steroid Biochem Mol Biol, 70, pp. 203-210 
504 |a Diederich, S., Quinkler, M., Miller, K., Heilmann, P., Schoneshofer, M., Oelkers, W., Human kidney 11 beta-hydroxysteroid dehydrogenase: Regulation by adrenocorticotropin? (1996) Eur J Endocrinol, 134, pp. 301-307 
504 |a Edwards, C., Stewart, P., Burt, D., Brett, L., McIntyre, M., Sutanto, W., De Kloet, E., Monder, C., Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor (1988) Lancet, 2, pp. 986-989 
504 |a Farman, N., Bocchi, B., Mineralocorticoid selectivity: Molecular and cellular aspects (2000) Kidney Int, 57, pp. 1364-1369 
504 |a Ferrari, P., Krozowski, Z., Role of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation (2000) Kidney Int, 57, pp. 1374-1381 
504 |a Ferrari, P., Obeyesekere, V., Li, K.X.Z., Aragona, F., Krozowski, Z., The 11 beta-hydroxysteroid dehydrogenase type II enzyme: Biochemical consequences of the congenital R337C mutation (1996) Steroids, 61, pp. 197-200 
504 |a Funder, J., Pearce, P., Smith, R., Smith, A., Mineralocorticoid action: Target tissue specificity is enzyme, not receptor mediated (1988) Science, 242, pp. 583-585 
504 |a Gomez-Sanchez, E., Gomez-Sanchez, C.E., Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone (1992) Am J Physiol, 263, pp. E1125-E1130 
504 |a Gomez-Sanchez, C., Murry, B., Kem, D., Kaplan, N., A direct radioimmunoassay of corticosterone in rat serum (1975) Endocrinology, 96, pp. 796-798 
504 |a Gomez-Sanchez, E., Ganjan, V., Chen, Y., Liu, Y., Clark, S., Gomez-Sanchez, C., The 11β-hydroxysteroid dehydrogenase 2 exists as an inactive dimer (2001) Steroids, 66, pp. 845-848 
504 |a Hawk, C.T., Li, L., Schafer, J.A., AVP and aldosterone at physiological concentrations have synergistic effects on Na transport in rat CCD (1996) Kidney Int, 50, pp. S35-S41 
504 |a Hirasawa, G., Takeyama, J., Sasano, H., Fukushima, K., Suzuki, T., Muramatu, Y., Darnel, A., Krozowski, Z., 11β-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta (2000) J Clin Endocrinol Metab, 85, pp. 1306-1309 
504 |a Igarreta, P., Calvo, J.C., Paladini, A., Damasco, C., Acute effects of two natural corticosteroids on the kinetics of the Na+/H+ exchanger in rat renal brush-border membranes (1997) Can J Physiol Pharm, 75, pp. 1226-1231 
504 |a Igarreta, P., Lantos, C., Calvo, J.C., Paladini, A., Damasco, C., Dose-dependence of the effects of corticosterone and the non-glucocorticoid 18-hydroxycorticosterone on the brush border Na +/H+ exchanger (1998) Endocr Res, 24, pp. 601-605 
504 |a Igarreta, P., Calvo, J.C., Damasco, C., Activity of renal 11βhydroxysteroid dehydrogenase 2 (11BHSD2) in stressed animals (1999) Life Sci, 64, pp. 2285-2290 
504 |a Jacobson, H., Kokko, J., Intrarenal heterogeneity: Vascular and tubular (1985) The Kidney: Physiology and Pathophysiology, pp. 531-580. , Seldin D, Giebisch G, editors, New York: Raven Press 
504 |a Kotelevtsev, Y., Brown, R., Flemings, Kenyon, C., Edwards, C., Seckl, J., Mullins, J., Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2 (1999) J Clin Invest, 103, pp. 683-689 
504 |a Koyama, K., Krozowski, Z., Modulation of 11 beta-hydroxysteroid dehydrogenase type 2 activity in Ishikawa cells is associated with changes in cellular proliferation (2001) Mol Cell Endocrinol, 183, pp. 165-170 
504 |a Krozowski, Z., The short-chain alcohol dehydrogenase superfamily: Variations on a common theme (1994) J Steroid Biochem Mol Biol, 51, pp. 125-130 
504 |a Krozowski, Z., Funder, J., Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity (1983) Proc Nat Acad Sci USA, 80, pp. 6056-6060 
504 |a Kurokawa, K., Cellular mechanisms and sites of hormone action in the kidney (1985) The Kidney: Physiology and Pathophysiology, pp. 739-774. , Seldin D, Giebisch G, editors. New York: Raven Press 
504 |a Leckie, C., Chapman, K., Edwards, C., Seckl, J., LLC-PK1 cells model 11βhydroxysteroid dehydrogenase type 2 regulation of glueocorticoid access to renal mineralocorticoid receptors (1995) Endocrinology, 136, pp. 5561-5569 
504 |a Li, K.X.Z., Smith, R., Ferrari, P., Funder, J., Krozowski, Z., Rat 11 beta-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney (1996) Mol Cell Endocrinol, 120, pp. 67-75 
504 |a Mantero, F., Palermo, M., Petrelli, M., Tedde, R., Stewart, P., Shackleton, C., Apparent mineralocorticoid excess: Type I and type II (1996) Steroids, 61, pp. 193-196 
504 |a Meier, J.R., Bull, R.J., Stober, J.A., Cimino, M.C., Evaluation of chemicals used for drinking water disinfection for production of chromosomal damage and sperm-head abnormalities in mice (1985) Environ Mutagen, 7, pp. 201-211 
504 |a Monder, C., Shackleton, C., 11 beta-hydroxysteroid dehydrogenase: Fact or fancy? (1984) Steroids, 44, pp. 383-417 
504 |a Monder, C., Stewart, P., Lakshmi, V., Valentino, R., Burt, D., Edwards, C., Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: In vivo and in vitro studies (1989) Endocrinology, 5, pp. 1046-1053 
504 |a Munck, A., Náray-Fejes-Tóth, A., The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited (1992) Mol Cell Endocrinol, 90, pp. C1-C4 
504 |a Munck, A., Náray-Fejes-Toth, A., Glucocorticoids and stress: Permissive and suppressive actions (1994) Ann NY Acad Sci, 746, pp. 115-130 
504 |a Nawrocki, A.R., Goldring, C.E., Kostadinova, R.M., Frey, F.J., Frey, B.M., In vivo footprinting of the human 11β-hydroxysteroid dehydrogenase type 2 promoter (2002) J Biol Chem, 277, pp. 14647-14656 
504 |a Obeyesekere, V., Ferrari, P., Andrews, R., Wilson, R., New, M., Funder, J., Krozowski, Z., The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydro-genase type II enzyme in a family with apparent mineralocorticoid excess (1995) J Clin Endocrinol Metab, 80, pp. 3381-3383 
504 |a Odermatt, A., Arnold, P., Frey, F., The intracellular localization of the mineralocorticoid receptor is regulated by 11β-hydroxysteroid dehydrogenase type 2 (2001) J Biol Chem, 276, pp. 28484-28492 
504 |a Pacak, K., Palkovits, M., Stressor specificity of control neuroendocrine responses: Implication for stress-related disorders (2001) Endocr Rev, 22, pp. 502-548 
504 |a Sapolsky, R., Romero, M., Munck, A., How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions (2000) Endocr Rev, 21, pp. 55-89 
504 |a Seckl, J.R., Walker, B.R., Minireview: 11β-hydroxysteroid dehydrogenase type 1-A tissue-specific amplifier of glucocorticoid action (2001) Endocrinology, 142, pp. 1371-1376 
504 |a Souness, G.W., Morris, D.J., The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat (1989) Endocrinology, 124, pp. 1588-1590 
504 |a Stewart, P., Krozowski, Z., 11 beta-hydroxysteroid dehydrogenase (1999) Vitam Horm, 57, pp. 249-324 
504 |a Suzuki, S., Koyama, K., Darnel, A., Ishibashi, H., Kobayashi, S., Kubo, H., Suzuki, T., Krozowski, Z., Dexamethasone up regulates 11{beta}-hydroxysteroid dehydrogenase type 2 in BEAS-2B cells (2003) Am J Respir Crit Care Med, 167, pp. 1244-1249 
504 |a Tanioka, H., Nakamura, K., Fujimura, S., Yoshida, M., Suzuki-Kusaba, M., Hisa, H., Satoh, S., Facilitatory role of NO in neural norepinephrine release in the rat kidney (2002) Am J Physiol: Reg: Integr Comp Physiol, 282, pp. R1436-R1442 
504 |a White, P.C., Mune, T., Agarwal, A.K., 11 beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess (1997) Endocr Rev, 18, pp. 135-156 
504 |a Ye, S., Zhong, H., Yanamadala, V., Campese, V., Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity (2002) Am J Hyper, 15, pp. 717-724 
520 3 |a Renal 11 β-hydroxysteroid dehydrogenase 2 (HSD2) catalyzes the conversion of active glucocorticoids to inert 11 β-keto compounds, thereby preventing the illicit binding of these hormones to mineralocorticoid receptors (MRs) and, thus, conferring aldosterone specificity. Absence or inhibition of HSD2 activity, originates a hypertensive syndrome with sodium retention and increased potassium elimination. Recent studies from our laboratory reported an increment of HSD2 activity in intact-stressed rats. To evaluate the adrenal involvement in this increase, we analyzed HSD2 activity and protein abundance in Intact, Sham-operated, and adrenalectomized rats under stress situations (gavage with an overload of 200 mM HCl (10 ml) and simulated gavage) or with corticosterone replacement. HSD2 activity was assessed in renal microsomal preparations obtained from different groups of animals. HSD2 protein abundance was measured by Western-blot. Circulating corticosterone was determined by radioimmunoassay. Sham-operated animals showed an increase in HSD2 activity and abundance compared to Intact and adrenalectomized rats suggesting the involvement of stress-related adrenal factors in HSD2 regulation. In the case of acidotic adrenalectomized animals, there was an increase in renal HSD2 activity when, along with the HCl overload, the rats were injected with corticosterone. This increment occurred without an increase in enzyme abundance. These results suggest the importance of circulating levels of glucocorticoids to respond to a metabolic acidosis, through regulation of HSD2 stimulation. The group subjected to a simulated gavage showed an increase in enzyme activity and protein abundance, thus demonstrating the need for both adrenal and extra-factors in the modulation of renal HSD2. The adrenalectomized animals injected with different doses of corticosterone, produced a progressive increase in enzyme activity and abundance, being significant for the dose of 68 ng corticosterone/100 g body weight. The highest dose (308 ng/100 g body weight) did not show any variation in activity and abundance compared to the control group. This biphasic effect of glucocorticoids could be explained taking into account their permissive and suppressive actions, depending on their blood levels. Knowing that stress induces multifactorial responses, it should not be suprising to observe a differential regulation in renal HSD2, confirming that different Stressors act through different factors of both, adrenal and extra-adrenal origin. © 2004 Wiley-Liss, Inc.  |l eng 
593 |a Department of Biological Chemistry, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires and PRHOM-CONICET, Buenos Aires, Argentina 
593 |a Instituto de Biología y Medicina Experimental (CONICET), Buenos Aires, Argentina 
593 |a Facultad de Ciencias Exactas y Naturales, Ciudad Universitaria-Núnez, (1428) Buenos Aires, Argentina 
690 1 0 |a ACIDOSIS 
690 1 0 |a CORTICOSTERONE 
690 1 0 |a HSD2 
690 1 0 |a KIDNEY 
690 1 0 |a STRESS 
690 1 0 |a 11BETA HYDROXYSTEROID DEHYDROGENASE 
690 1 0 |a CHLORIDE 
690 1 0 |a CORTICOSTERONE 
690 1 0 |a GLUCOCORTICOID 
690 1 0 |a CORTICOSTERONE 
690 1 0 |a ADRENAL GLAND 
690 1 0 |a ADRENALECTOMY 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ARTICLE 
690 1 0 |a BODY WEIGHT 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a ENZYME REGULATION 
690 1 0 |a FEEDING 
690 1 0 |a METABOLIC ACIDOSIS 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a RADIOIMMUNOASSAY 
690 1 0 |a RAT 
690 1 0 |a STRESS 
690 1 0 |a WESTERN BLOTTING 
690 1 0 |a ADRENAL GLAND 
690 1 0 |a ANIMAL 
690 1 0 |a BLOOD 
690 1 0 |a ENZYMOLOGY 
690 1 0 |a GENE EXPRESSION REGULATION 
690 1 0 |a KIDNEY 
690 1 0 |a KINETICS 
690 1 0 |a METABOLISM 
690 1 0 |a PHYSIOLOGY 
690 1 0 |a ANIMALIA 
690 1 0 |a 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 
690 1 0 |a ADRENAL GLANDS 
690 1 0 |a ADRENALECTOMY 
690 1 0 |a ANIMALS 
690 1 0 |a CORTICOSTERONE 
690 1 0 |a GENE EXPRESSION REGULATION, ENZYMOLOGIC 
690 1 0 |a KIDNEY 
690 1 0 |a KINETICS 
690 1 0 |a MODELS, ANIMAL 
690 1 0 |a RATS 
700 1 |a Matkovic, L. 
700 1 |a Calvo, J.C. 
700 1 |a Damasco, M.C. 
773 0 |d 2004  |g v. 92  |h pp. 591-602  |k n. 3  |p J. Cell. Biochem.  |x 07302312  |t Journal of Cellular Biochemistry 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-16544364369&doi=10.1002%2fjcb.20078&partnerID=40&md5=71304543ab7b0c3dda86261477e3a42c  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1002/jcb.20078  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_07302312_v92_n3_p591_Zallocchi  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_07302312_v92_n3_p591_Zallocchi  |y Registro en la Biblioteca Digital 
961 |a paper_07302312_v92_n3_p591_Zallocchi  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 65269